Augmentation of Therapeutic Angiogenesis Using Genetically Modified Human Endothelial Progenitor Cells with Altered Glycogen Synthase Kinase-3β ActivityJin‐Ho Choi, Hyo-Soo Kim|Journal of Biological Chemistry|2004Cited by 96
KAI1(CD82) is a key molecule to control angiogenesis and switch angiogenic milieu to quiescent stateJin Woo Lee, Hyo-Soo Kim|Journal of Hematology & Oncology|2021Cited by 49